Jacques Cadranel

10PUBLICATIONS
74CO-AUTHORS
Predictive and prognostic markersAllergyDisease surveillanceCancer therapy (excl. chemotherapy and radiation therapy)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Sep 10, 2026
COVID-19 vaccination around immune checkpoint inhibitor start and survival in a nationwide cohort of patients with cancer.

|Mar 10, 2026
The STING HAQ haplotype and clinical non-penetrance in COPA syndrome.

Clémence David, Tifenn Wauquier, Alix de Becdelièvre

|Nov 20, 2025
Cancer risks and trends between 1997 and 2018, and effects of restored immunity in people living with HIV: Results from the ANRS CO4 French hospital database on HIV.

Sophie Grabar, Paula Lakrout, Valérie Potard

|Jan 25, 2025
Patterns of Treatment and Real-World Outcomes of Patients With Non-small Cell Lung Cancer With EGFR Exon 20 Insertion Mutations Receiving Mobocertinib: The EXTRACT Study.

Geoffrey Liu, Shi Feng Nyaw, Tony S K Mok

|Oct 21, 2024
Efficacy of first-line immune checkpoint inhibitors in pulmonary sarcomatoid carcinoma.

Gary Birsen, Valérie Gounant, Nicolas Girard

|Sep 23, 2022
Exposure-Response Analysis of Osimertinib in Patients with Advanced Non-Small-Cell Lung Cancer.

Thomas Rodier, Alicja Puszkiel, Evelina Cardoso

Pageof 2

Frequent Collaborators

2 joint publications

Marie Wislez

1 joint publications

Lionel Piroth

1 joint publications

Catherine Quantin

1 joint publications

Marine Baron